Close

New York DOJ Attorney Announces Charges Against Two Former Valeant Pharma (VRX) Execs

Go back to New York DOJ Attorney Announces Charges Against Two Former Valeant Pharma (VRX) Execs

Additional Charges Against Valeant Pharma (VRX) or Former Execs Cannot Be Ruled Out - Wells Fargo's Maris

November 17, 2016 1:46 PM EST

Wells Fargo analyst David Maris weighed in on Valeant Pharma (NYSE: VRX) after today's DOJ press conference. Maris said based on the comments additional charges against Valeant or former Valeant executives cannot be ruled out,

Maris commented, "Earlier in the day, a Valeant... More

Valeant Pharma (VRX) Off Lows as Charges Relate to Employee Fraud Versus Company Fraud

November 17, 2016 11:45 AM EST

Valeant Pharma (NYSE: VRX) is bouncing off morning lows as the charges against former exec Gary Tanner and CEO the Philidor Andrew Davenport appear more related to individual fraud versus company fraud. Shares of VRX are down 2% after trading down 7%... More

Valeant Pharma (VRX) Comments on Philidor Criminal Complaint; Says Co., Former CEO/CFO Not Yet Charged

November 17, 2016 10:48 AM EST

Valeant Pharmaceuticals International, Inc. (NYSE: VRX) learned that a criminal complaint was filed in relation to Philidor. Gary Tanner and Andrew Davenport were charged in the matter. The company, former CEO, former CFO, and current executives have not been charged at this... More

Two Valeant (VRX) -Linked Executives Said to be Arrested Thursday - Bloomberg

November 17, 2016 9:36 AM EST

(Updated)

Two executives linked to Valeant Pharma (NYSE: VRX) were said to be arrested Thursday, according to Bloomberg. Those arrested included Gary Tanner, former executive at Valeant, and Andrew Davenport, former CEO of Philidor Rx.

... More

Valeant Pharma (VRX) Lower as Philidor Charges Said Imminent

November 17, 2016 9:29 AM EST

Valeant Pharma (NYSE: VRX) is modestly lower pre-open on reports charges are coming imminently at Philidor. Shares are down 1%.

... More